[Autoimmune blistering diseases].
Amagai
Masayuki
M
Department of Dermatology, Keio University School of Medicine.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001324:Autoantigens / Q000276:immunology; D015551:Autoimmunity; D003176:Complement C3; D003598:Cytoskeletal Proteins / Q000276:immunology; D051180:Desmoplakins; D006801:Humans; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D024041:Non-Fibrillar Collagens; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000628:therapy; D010391:Pemphigoid, Bullous / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000628:therapy; D010392:Pemphigus / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000628:therapy; D010951:Plasma Exchange; D011379:Prognosis; D005719:gamma-Globulins / Q000008:administration & dosage; D000097805:Collagen Type XVII
D000305:Adrenal Cortex Hormones; D001324:Autoantigens; D003176:Complement C3; D003598:Cytoskeletal Proteins; D051180:Desmoplakins; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D024041:Non-Fibrillar Collagens; D005719:gamma-Globulins; D000097805:Collagen Type XVII